Nonhomologous End-Joining Factor 1 (NHEJ1) (C-Term) Peptide
Quick Overview for Nonhomologous End-Joining Factor 1 (NHEJ1) (C-Term) Peptide (ABIN980699)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- IDSQCVNQPE QLVSSAPTLS APEKESTGTS GPLQRPQLSK VKRKKPRGLF
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-NHEJ1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- NHEJ1 (Nonhomologous End-Joining Factor 1 (NHEJ1))
-
Background
-
Double-strand breaks in DNA result from genotoxic stresses and are among the most damaging of DNA lesions. This gene encodes a DNA repair factor essential for the nonhomologous end-joining pathway, which preferentially mediates repair of double-stranded breaks. Mutations in this gene cause different kinds of severe combined immunodeficiency disorders.
Alias Symbols: FLJ12610, XLF
Protein Size: 299 -
Molecular Weight
- 33 kDa
-
Gene ID
- 79840
-
NCBI Accession
- NM_024782, NP_079058
-
UniProt
- Q9H9Q4
Target
-